Rinvoq ER 45 MG tablet UU 28S
Ended Awarded
- Contract number
- SPE2DB25FWHCL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,143
Award facts
- Contract value 100% obligated
- $31,142.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $31,142.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for RINVOQ ER 45 mg tablets (Upadacitinib extended-release), a immunosuppressive medication commonly used to treat rheumatoid arthritis and other inflammatory conditions. This non-set-aside, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems.
This delivery order falls within AmerisourceBergen's comprehensive pharmaceutical supply portfolio with the Defense Logistics Agency, which encompasses brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains. The company's DLA Troop Support Medical contract functions as a global pharmaceutical support vehicle enabling supply to military healthcare programs worldwide, while also serving other federal customers including the Defense Health Agency and U.S. Coast Guard. The ultimate completion date for this specific delivery order is April 24, 2025, with performance taking place at the company's Conshohocken, Pennsylvania location.
Quick answers
Who was awarded contract SPE2DB25FWHCL?
SPE2DB25FWHCL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 23, 2025.
How much is contract SPE2DB25FWHCL worth?
The government has obligated $31,143 on SPE2DB25FWHCL.
Is contract SPE2DB25FWHCL an order under another contract?
Yes. SPE2DB25FWHCL is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB25FWHCL competed?
The extent of competition for SPE2DB25FWHCL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award